Joshua Lehrer-Graiwer
Fortune : 40 044 $ au 30/09/2026
Fortune : 40 044 $ au 30/09/2026
Dr. Joshua Lehrer-Graiwer, MD, is a President & Chief Operating Officer at Lisata Therapeutics, Inc. and an Independent Director at Fulcrum Therapeutics, Inc. He is on the Board of Directors at Fulcrum Therapeutics, Inc. Dr. Lehrer-Graiwer was previously employed as a President, Chief Executive Officer & Director by Marea Therapeutics, Inc., a President, CEO, CFO, CAO & Director by Graphite Bio, Inc., and a Chief Medical Officer by Global Blood Therapeutics, Inc. He received his undergraduate degree from Harvard University, a graduate degree from the University of Cambridge and a doctorate degree from The University of California, San Francisco.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/09/2026 | 27 808 ( 0,31% ) | 40 044 $ | 30/09/2026 | |
| 23/04/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 23/04/2026 |
| LISATA THERAPEUTICS, INC. | President | 17/09/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| LENZ THERAPEUTICS, INC. | Directeur Général | 21/08/2023 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 17/04/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national